Bevacizumab

Grey

Brand Name(s):Avastin

Indication:Renal cell cancer (Advanced and/or Metastatic), Metastatic cancer of colon or rectum

Rationale:1

Considered:Jan-08

Review Date:Jul-20

Comments:
NICE TA 242
NICE unable to recommend for use
Details available at:https://www.nice.org.uk/guidance/ta242
Jan 2012